The role of apelin in cardiovascular diseases, obesity and cancer

MB Wysocka, K Pietraszek-Gremplewicz… - Frontiers in …, 2018 - frontiersin.org
Apelin is an endogenous peptide identified as a ligand of the G protein-coupled receptor
APJ. Apelin belongs to the family of adipokines, which are bioactive mediators released by …

Targeting the apelin system for the treatment of cardiovascular diseases

FA Chapman, JJ Maguire, DE Newby… - Cardiovascular …, 2023 - academic.oup.com
Cardiovascular disease is the leading cause of death worldwide. Its prevalence is rising due
to ageing populations and the increasing incidence of diseases such as chronic kidney …

Sex difference in human diseases: mechanistic insights and clinical implications

Y Shi, J Ma, S Li, C Liu, Y Liu, J Chen, N Liu… - Signal transduction and …, 2024 - nature.com
Sex characteristics exhibit significant disparities in various human diseases, including
prevalent cardiovascular diseases, cancers, metabolic disorders, autoimmune diseases …

The role of apelin–APJ system in diabetes and obesity

C Li, H Cheng, BK Adhikari, S Wang, N Yang… - Frontiers in …, 2022 - frontiersin.org
Nowadays, diabetes and obesity are two main health-threatening metabolic disorders in the
world, which increase the risk for many chronic diseases. Apelin, a peptide hormone, exerts …

Apelin and energy metabolism

C Bertrand, P Valet, I Castan-Laurell - Frontiers in physiology, 2015 - frontiersin.org
A wide range of adipokines identified over the past years has allowed considering the white
adipose tissue as a secretory organ closely integrated into overall physiological and …

Sex differences in the genome-wide DNA methylation pattern and impact on gene expression, microRNA levels and insulin secretion in human pancreatic islets

E Hall, P Volkov, T Dayeh, JLS Esguerra, S Salö… - Genome biology, 2014 - Springer
Background Epigenetic factors regulate tissue-specific expression and X-chromosome
inactivation. Previous studies have identified epigenetic differences between sexes in some …

Apelin, diabetes, and obesity

I Castan-Laurell, C Dray, C Attané, T Duparc, C Knauf… - Endocrine, 2011 - Springer
Apelin is a peptide known as the ligand of the G-protein-coupled receptor APJ. Several
active apelin forms exist such as apelin-36, apelin-17, apelin-13, and the pyroglutamated …

Apelin in disease

H Antushevich, M Wójcik - Clinica chimica acta, 2018 - Elsevier
Apelin, a regulatory peptide, is a ligand of the APJ receptor that belongs to the G protein-
coupled receptor family. Apelin and APJ are widely distributed in the body and play potential …

[HTML][HTML] Adipose tissue secretion pattern influences β-cell wellness in the transition from obesity to type 2 diabetes

G Biondi, N Marrano, A Borrelli, M Rella… - International journal of …, 2022 - mdpi.com
The dysregulation of the β-cell functional mass, which is a reduction in the number of β-cells
and their ability to secure adequate insulin secretion, represents a key mechanistic factor …

Apelin, a promising target for type 2 diabetes treatment?

I Castan-Laurell, C Dray, C Knauf, O Kunduzova… - Trends in Endocrinology …, 2012 - cell.com
Insulin resistance is a main feature of obesity and type 2 diabetes mellitus (T2DM). Several
mechanisms linking obesity to insulin resistance have been proposed. Adipose tissue …